EXELIXIS (EX9 BE) stock market data APIs
€36.041
0(0%)
as of March 18, 2026
Try our APIs with
free plan!
EXELIXIS Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for EX9.BE.
Prev. Close
36.041
Open
36.041
High
36.041
Low
36.041
52 wk Range
29.61-41.51
Market Cap
4 665 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get EXELIXIS data using free add-ons & libraries
Get EXELIXIS Fundamental Data
EXELIXIS Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
EXELIXIS News
New
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in March
- Presentations to be webcast on www.exelixis.com - ALAMEDA, Calif., February 24, 2026--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced that company management will participate in fire...
Here’s What Analysts Think About Arcus Biosciences (RCUS)
Arcus Biosciences, Inc. (NYSE:RCUS) is one of the best immunotherapy stocks to buy according to hedge funds. On February 12, Arcus Biosciences, Inc. (NYSE:RCUS) was downgraded to Equal Weight from Ove...
Exelixis, Inc. (EXEL): A Bull Case Theory
We came across a bullish thesis on Exelixis, Inc. on Business Invest’s Substack by Francesco Ferrari. In this article, we will summarize the bulls’ thesis on EXEL. Exelixis, Inc.'s share was tradi...
Will Exelixis (EXEL) Beat Estimates Again in Its Next Earnings Report?
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Exelixis (EXEL), which belongs to the Zacks Medic...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
